Published in Neurotherapeutics on July 01, 2011
Safety and outcomes of intravenous thrombolysis in dissection-related ischemic stroke: an international multicenter study and comprehensive meta-analysis of reported case series. J Neurol (2015) 0.80
Heads Up! A Novel Provocative Maneuver to Guide Acute Ischemic Stroke Management. Interv Neurol (2016) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke (2004) 8.77
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med (1998) 6.88
Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood (1998) 6.72
Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet (2004) 5.93
CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet (1997) 5.27
Heparin treatment in sinus venous thrombosis. Lancet (1991) 5.02
Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol (2007) 4.68
Polymyalgia rheumatica and temporal arteritis: diagnosis and management. BMJ (1997) 4.30
Cerebral venous thrombosis--a review of 38 cases. Stroke (1985) 4.12
Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med (2007) 4.04
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol (2007) 3.72
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet (2001) 3.69
Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke (1999) 3.42
Stroke patterns of internal carotid artery dissection in 40 patients. Stroke (1998) 2.76
Dissections of cervical and cerebral arteries. Neurol Clin (1983) 2.31
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med (1998) 2.30
Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med (1995) 2.17
Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology (2005) 2.06
Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) (1988) 1.98
Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology (2009) 1.98
Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol (2004) 1.90
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol (2007) 1.79
Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option? Cephalalgia (2003) 1.79
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J (2000) 1.72
Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol (2004) 1.63
Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology (2003) 1.56
Treatment of cervical artery dissection: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2008) 1.44
Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum (2002) 1.40
Spontaneous internal carotid artery dissection: early diagnosis and management in 44 patients. J Neurol (1995) 1.39
Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke (2005) 1.35
Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica (2003) 1.34
Angioplasty and stenting in carotid dissection with or without associated pseudoaneurysm. AJNR Am J Neuroradiol (2005) 1.30
Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology (1998) 1.30
Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke (2000) 1.17
Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev (2003) 1.15
Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): the role of calcium antagonists. Cephalalgia (2003) 1.02
Stroke prevention and treatment in sickle cell disease. Arch Neurol (2001) 1.00
Urgent carotid endarterectomy in patients with recent/crescendo transient ischaemic attacks or acute stroke. Eur J Vasc Endovasc Surg (2010) 0.94
Successful delayed thrombolysis for cerebral venous and dural sinus thrombosis: a case report and review of the literature. J Stroke Cerebrovasc Dis (2008) 0.91
Cervical artery dissections. Eur Neurol (1997) 0.91
IV thrombolysis in patients with acute stroke due to spontaneous carotid dissection. Neurology (2005) 0.90
Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group. Stroke (1984) 0.89
Pressor therapy in acute ischemic stroke: systematic review. Stroke (2006) 0.88
Cerebral infarction secondary to sickle cell disease: arteriographic findings. AJR Am J Roentgenol (1980) 0.87
Endovascular treatment of extensive cerebral sinus thrombosis. J Neurosurg (2009) 0.87
Temporal arteritis: a clinical approach. J Am Geriatr Soc (1999) 0.85
Intravenous tPA in acute ischemic stroke related to internal carotid artery dissection. Neurology (2000) 0.83
Endovascular mechanical recanalisation of acute carotid-T occlusions: a single-center retrospective analysis. Cardiovasc Intervent Radiol (2010) 0.82
Early carotid surgery in patients after acute ischemic stroke: is it safe? A retrospective analysis in a single center between early and delayed/deferred carotid surgery on 285 patients. Ann Vasc Surg (2010) 0.81
Endovascular management of symptomatic vertebral artery dissection achieved using stent angioplasty and emboli protection device. Neurol Res (2003) 0.80
High-dose methylprednisolone prevents vasospasm after subarachnoid hemorrhage through inhibition of protein kinase C activation. Neurol Res (2002) 0.79
Recurrent stroke after cervical artery dissection. J Neurol Neurosurg Psychiatry (2010) 0.78
Cerebrovascular disease. Pathophysiology and diagnosis. Nurs Clin North Am (1986) 0.78
The timing of carotid endarterectomy post stroke. Neurol Clin (2006) 0.78
[Non-complicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent. Evaluation of 15 patients]. Rev Med Interne (2001) 0.76
Intraarterial thrombolysis and stent placement in the acute phase of blunt internal carotid artery trauma with subocclusive dissection and thromboembolic complication: case report and review of the literature. Ann Vasc Surg (2005) 0.76
Extracranial cervical artery dissection. Stroke (2000) 0.76
Major intracerebral arterial involvement in sickle cell disease. Surg Neurol (1980) 0.76
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation (2002) 2.71
The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol (2008) 2.38
Comprehensive stroke centers overcome the weekend versus weekday gap in stroke treatment and mortality. Stroke (2011) 2.01
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation (2008) 1.84
Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke (2006) 1.80
Optical bedside monitoring of cerebral blood flow in acute ischemic stroke patients during head-of-bed manipulation. Stroke (2014) 1.62
Sulfonylurea use before stroke does not influence outcome. Stroke (2011) 1.60
Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke (2009) 1.56
CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke (2007) 1.55
Middle cerebral artery vasospasm: transcranial color-coded duplex sonography versus conventional nonimaging transcranial Doppler sonography. Crit Care Med (2009) 1.53
Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke (2003) 1.51
Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery (2011) 1.51
Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis (2003) 1.49
Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients. Opt Express (2009) 1.46
Paracetamol for stroke: easy in practice, but not in trials. Lancet Neurol (2009) 1.41
Headache as a risk factor for neurovascular events in pediatric brain tumor patients. Neurology (2013) 1.41
Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care (2009) 1.40
Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke (2008) 1.38
Carotid artery diameter in men and women and the relation to body and neck size. Stroke (2006) 1.35
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage. J Neurosci (2014) 1.31
Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc (2013) 1.22
Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke (2012) 1.18
Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses. Stroke (2005) 1.14
ABC/XYZ estimates intracerebral hemorrhage volume as a percent of total brain volume in children. Stroke (2010) 1.13
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J (2013) 1.12
Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol (2011) 1.11
Disparities in evaluation at certified primary stroke centers: reasons for geographic and racial differences in stroke. Stroke (2013) 1.11
Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09
Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke (2013) 1.08
Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clin Neurol Neurosurg (2003) 1.08
Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci (2003) 1.05
Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging (2009) 1.04
Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke (2009) 1.01
Bow hunter's syndrome caused by accessory cervical ossification: posterolateral decompression and the use of intraoperative Doppler ultrasonography. Surg Neurol (2006) 1.00
Neutrophil depletion diminishes monocyte infiltration and improves functional outcome after experimental intracerebral hemorrhage. Acta Neurochir Suppl (2011) 0.99
Who will consent to emergency treatment trials for subarachnoid hemorrhage? Acad Emerg Med (2009) 0.95
Pseudo-subarachnoid hemorrhage: report of three cases and review of the literature. Neurocrit Care (2004) 0.93
Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage. Neurocrit Care (2007) 0.92
D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification. J Stroke Cerebrovasc Dis (2009) 0.92
Autologous blood injection to model spontaneous intracerebral hemorrhage in mice. J Vis Exp (2011) 0.91
Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort. Front Neurol (2012) 0.91
Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol (2004) 0.90
Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit Care Med (2004) 0.90
Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke (2012) 0.90
Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes (2012) 0.88
Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation (2008) 0.87
Treatment of intracranial arterial stenosis. Expert Rev Neurother (2006) 0.87
Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke (2009) 0.87
Hemorrhagic transformation of childhood arterial ischemic stroke. Stroke (2011) 0.86
Ischemic strokes after cardiac catheterization: opportune thrombolysis candidates? Arch Neurol (2006) 0.86
Fatal subacute cytomegalovirus encephalitis associated with hypogammaglobulinemia and thymoma. Mayo Clin Proc (2003) 0.86
Seizures do not increase in-hospital mortality after intracerebral hemorrhage in the nationwide inpatient sample. Neurocrit Care (2013) 0.84
Safety and tolerability of arundic acid in acute ischemic stroke. J Neurol Sci (2006) 0.84
Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke (2013) 0.84
Informed consent: the rate-limiting step in acute stroke trials. Front Neurol (2011) 0.83
A pilot study of darbepoetin alfa for prophylactic neuroprotection in aortic surgery. Neurocrit Care (2013) 0.83
Neurologic outcomes from high risk descending thoracic and thoracoabdominal aortic operations in the era of endovascular repair. Neurocrit Care (2008) 0.83
A fresh twist on carotid artery dissections. Neurology (2009) 0.83
Concurrent validity and reliability of retrospective scoring of the Pediatric National Institutes of Health Stroke Scale. Stroke (2011) 0.82
Effect of arundic acid on serum S-100beta in ischemic stroke. J Neurol Sci (2006) 0.82
Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists. J Stroke Cerebrovasc Dis (2013) 0.82
Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS. Neurology (2012) 0.81
Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography. Am J Cardiol (2002) 0.81
Red blood cell transfusion increases the risk of thrombotic events in patients with subarachnoid hemorrhage. Neurocrit Care (2014) 0.80
Intracranial vertebrobasilar artery dissection associated with postpartum angiopathy. Stroke Res Treat (2009) 0.80
PFO management: neurologists vs cardiologists. Neurology (2005) 0.79
Current management of symptomatic intracranial stenosis. Curr Atheroscler Rep (2011) 0.79
TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J Clin Invest (2016) 0.79
Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study. J Stroke Cerebrovasc Dis (2010) 0.79
Transient global amnesia heralding basilar artery thrombosis. Clin Neurol Neurosurg (2004) 0.78
Predictive validity of severity grading for cerebral steno-occlusive arteriopathy in recurrent childhood ischemic stroke. Int J Stroke (2014) 0.78
Stroke associated with Barth syndrome. J Child Neurol (2006) 0.78
Thromboelastography defines late hypercoagulability after TBI: a pilot study. Neurocrit Care (2015) 0.78
Editorial comment--More than one way to lyse a clot. Stroke (2004) 0.77
Carotid dissection causing occipital lobe infarction. Neurology (2005) 0.77
Clinical, lifestyle, socioeconomic determinants and rate of asymptomatic intracranial atherosclerosis in stroke free Pakistanis. BMC Neurol (2014) 0.76
Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia. Am J Hematol (2007) 0.76
Predicting early awakening from coma after intracerebral hemorrhage. Front Neurol (2013) 0.76
All patients should be admitted to the hospital after a transient ischemic attack. Stroke (2012) 0.76
Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey. J Stroke Cerebrovasc Dis (2007) 0.76
In the clinic. Transient ischemic attack. Ann Intern Med (2011) 0.76
Pure sensory stroke from cortical infarction. Neurology (2002) 0.75
Limitations of threshold-based brain oxygen monitoring for seizure detection. Neurocrit Care (2011) 0.75
Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage. Thromb Haemost (2017) 0.75
Endocarditis is a common stroke mechanism in hemodialysis patients. Stroke (2014) 0.75
A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke. Lancet Neurol (2010) 0.75
Folate and the risk of stroke: fortify first and ask questions later? Stroke (2002) 0.75
Intravenous thrombolysis for acute ischemic stroke: the phase IV data. J Stroke Cerebrovasc Dis (2007) 0.75
Interprovider Communication Using a Scheduled Provider Alert-Response Communication System in 3 Inpatient Neurology Units. J Neurosci Nurs (2017) 0.75